Influenza vaccine effectiveness: best practice and current limitations of the screening method and their implications for the clinic

References

• Stohr K. Influenza – WHO cares. Lancet Infect Dis 2002;2(9):517
   PubMed Web of Science ®Google Scholar
• Mao L, Yang Y, Qiu Y. Annual economic impacts of seasonal influenza on US counties: spatial heterogeneity and patterns. Int J Health Geogr 2012;11:
   PubMed Web of Science ®Google Scholar
• Morbidity and Mortality Weekly Report (MMWR). Summary recommendations: prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices – (ACIP) – United States, 2013-14. Available from: www.cdc.gov/flu/professionals/acip/2013-summary-recommendations.htm
   Google Scholar
• Hannoun C. The evolving history of influenza viruses and influenza vaccines. Expert Rev Vaccines 2013;12(9):1085-94
   PubMed Web of Science ®Google Scholar
• Jefferson T, Rivetti D, Rivetti A, et al. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 2005;366(9492):1165-74
   PubMed Web of Science ®Google Scholar
• Carrat F, Tachet A, Rouzioux C, et al. Field investigation of influenza vaccine effectiveness on morbidity. Vaccine 1998;16(9-10):893-8
   PubMed Web of Science ®Google Scholar
• De Serres G, Skowronski DM, Wu XW, Ambrose CS. The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials. Euro Surveill 2013;18:37
   Google Scholar
• Shim E, Galvani AP. Distinguishing vaccine efficacy and effectiveness. Vaccine 2012;30(47):6700-5
   PubMed Web of Science ®Google Scholar
• Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010;59(RR-8):1-62
   PubMedGoogle Scholar
• Orenstein EW, De Serres G, Haber MJ, et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol 2007;36(3):623-31
   PubMed Web of Science ®Google Scholar
• Valenciano M, Kissling E, Ciancio BC, Moren A. Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks. Vaccine 2010;28(46):7381-8
   PubMed Web of Science ®Google Scholar
• Valenciano M, Ciancio B. I-MOVE: a European network to measure the effectiveness of influenza vaccines. Euro Surveill 2012;17:39
   Google Scholar
• Kissling E, Valenciano M. Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study. Euro Surveill 2011;16:11
   PubMedGoogle Scholar
• Castilla J, Martinez-Baz I, Martinez-Artola V, et al. Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis. Euro Surveill 2013;18(7):2
   PubMedGoogle Scholar
• Jimenez-Jorge S, de Mateo S, Pozo F, et al. Early estimates of the effectiveness of the 2011/12 influenza vaccine in the population targeted for vaccination in Spain, 25 December 2011 to 19 February 2012. Euro Surveill 2012;17:12
   PubMedGoogle Scholar
• Legrand J, Vergu E, Flahault A. Real-time monitoring of the influenza vaccine field effectiveness. Vaccine 2006;24(44-46):6605-11
   PubMed Web of Science ®Google Scholar
• Pelat C, Falchi A, Carrat F, et al. Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 A(H1N1) influenza: estimations from surveillance data in France. PLoS One 2011;6(5):e19621
   Web of Science ®Google Scholar
• Seyler T, Bella A, Puzelli S, et al. Estimating pandemic vaccine effectiveness in two Italian regions using the screening method, 2009-2010. Vaccine 2012;30(2):109-11
   PubMed Web of Science ®Google Scholar
• Farrington CP. Estimation of vaccine effectiveness using the screening method. Int J Epidemiol 1993;22(4):742-6
   PubMed Web of Science ®Google Scholar
• Chen RT, Orenstein WA. Epidemiologic methods in immunization programs. Epidemiol Rev 1996;18(2):99-117
   PubMed Web of Science ®Google Scholar
• Orenstein WA, Bernier RH, Hinman AR. Assessing vaccine efficacy in the field. Further observations. Epidemiol Rev 1988;10:212-41
   PubMed Web of Science ®Google Scholar
• Cohen AL, Taylor T Jr, Farley MM, et al. An assessment of the screening method to evaluate vaccine effectiveness: the case of 7-valent pneumococcal conjugate vaccine in the United States. PLoS One 2012;7(8):e41785
   Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Measles vaccine efficacy-United States. Morb Mortal Wkly Rep 1980;29:470-2
   Google Scholar
• Ramsay ME, McVernon J, Andrews NJ, et al. Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method. J Infect Dis 2003;188(4):481-5
   PubMed Web of Science ®Google Scholar
• Guris D, Strebel PM, Tachdjian R, et al. Effectiveness of the pertussis vaccination program as determined by use of the screening method: united States, 1992-1994. J Infect Dis 1997;176(2):456-63
   PubMed Web of Science ®Google Scholar
• McMorrow ML, Gebremedhin G, van den Heever J, et al. Measles outbreak in South Africa, 2003-2005. S Afr Med J 2009;99(5):314-19
   PubMed Web of Science ®Google Scholar
• Trotter CL, Andrews NJ, Kaczmarski EB, et al. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet 2004;364(9431):365-7
   PubMed Web of Science ®Google Scholar
• Cohen C, White JM, Savage EJ, et al. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis 2007;13(1):12-17
   PubMed Web of Science ®Google Scholar
• Falchi A, Souty C, Grisoni ML, et al. Field seasonal influenza vaccine effectiveness: Evaluation of the screening method using different sources of data during the 2010/2011 French influenza season. Hum Vaccin Immunother 2013;9:11
   PubMed Web of Science ®Google Scholar
• Greenwood M YG. The statistics of antityphoid and anti-cholera inoculations, and the interpretation of such statistics in general. Proc R Soc Med 1915;8:113-94
   PubMedGoogle Scholar
• Orenstein WA, Bernier RH, Dondero TJ, et al. Field evaluation of vaccine efficacy. Bull World Health Organ 1985;63(6):1055-68
   PubMed Web of Science ®Google Scholar
• Nichol KL, Nordin JD, Nelson DB, et al. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 2007;357(14):1373-81
   PubMed Web of Science ®Google Scholar
• Hak E, Verheij TJ, Grobbee DE, et al. Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications. J Epidemiol Community Health 2002;56(12):951-5
   PubMed Web of Science ®Google Scholar
• Jackson LA, Jackson ML, Nelson JC, et al. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 2006;35(2):337-44
   PubMed Web of Science ®Google Scholar
• Simonsen L, Viboud C, Taylor RJ, et al. Influenza vaccination and mortality benefits: new insights, new opportunities. Vaccine 2009;27(45):6300-4
   PubMed Web of Science ®Google Scholar
• Bonmarin I, Belchior E, Le Strat Y, Levy-Bruhl D. First estimates of influenza vaccine effectiveness among severe influenza cases, France, 2011/12. Euro Surveill 2012;17:18
   Google Scholar
• Thomas HL, Andrews N, Green HK, et al. Estimating vaccine effectiveness against severe influenza in England and Scotland 2011/2012: applying the screening method to data from intensive care surveillance systems. Epidemiol Infect 2014;142(1):126-33
   PubMed Web of Science ®Google Scholar
• WHO recommendations on the use of rapid testing for influenza diagnosis. 2005. Available from: www.who.int/influenza/resources/documents/RapidTestInfluenza_WebVersion.pdf
   Google Scholar
• Thomas RE. Is influenza-like illness a useful concept and an appropriate test of influenza vaccine effectiveness? Vaccine 2014;32(19):2143-9
   PubMed Web of Science ®Google Scholar
• Turbelin C, Souty C, Pelat C, et al. Age distribution of influenza like illness cases during post-pandemic A(H3N2): comparison with the twelve previous seasons, in France. PLoS One 2013;8(6):e65919
   Web of Science ®Google Scholar
• Savulescu C, Valenciano M, de Mateo S, Larrauri A. Estimating the influenza vaccine effectiveness in elderly on a yearly basis using the Spanish influenza surveillance network--pilot case-control studies using different control groups, 2008-2009 season, Spain. Vaccine 2010;28(16):2903-7
   PubMed Web of Science ®Google Scholar
• Wichmann O, Siedler A, Sagebiel D, et al. Further efforts needed to achieve measles elimination in Germany: results of an outbreak investigation. Bull World Health Organ 2009;87(2):108-15
   PubMed Web of Science ®Google Scholar
• Torvaldsen S, McIntyre PB. Observational methods in epidemiologic assessment of vaccine effectiveness. Commun Dis Intell Q Rep 2002;26(3):451-7
   PubMedGoogle Scholar
• Lister S, McIntyre PB, Burgess MA, O’Brien ED. Immunisation coverage in Australian children: a systematic review 1990-1998. Commun Dis Intell 1999;23(6):145-70
   PubMedGoogle Scholar
• Cox RJ, Brokstad KA, Ogra P. Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scand J Immunol 2004;59(1):1-15
   PubMed Web of Science ®Google Scholar
• Tuppin P, Choukroun S, Samson S, et al. [Vaccination against seasonal influenza in France in 2010 and 2011: decrease of coverage rates and associated factors]. Presse Med 2012;41(11):e568-76
   Google Scholar
• Guthmann JP, Fonteneau L, Bonmarin I, Levy-Bruhl D. Influenza vaccination coverage one year after the A(H1N1) influenza pandemic, France, 2010-2011. Vaccine 2012;30(6):995-7
   PubMed Web of Science ®Google Scholar
• Privileggio L, Falchi A, Grisoni ML, et al. Rates of immunization against pandemic and seasonal influenza in persons at high risk of severe influenza illness: a cross-sectional study among patients of the French Sentinelles general practitioners. BMC Public Health 2013;13:246
   PubMed Web of Science ®Google Scholar
• Foppa IM, Haber M, Ferdinands JM, Shay DK. The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine 2013;31(30):3104-9
   PubMed Web of Science ®Google Scholar